Boehringer Ingelheim Renews Global SRS License
News May 22, 2006
SRS has been in use at Boehringer Ingelheim for the past 5 years and is an integral part of its Bioinformatics platform.
As part of the renewal agreement BioWisdom SRS will be responsible for upgrading the Biberach (Germany) and Ridgefield (USA) sites to new versions of the software.
"Renewing customers is the best endorsement for the SRS product," said Gordon Smith Baxter, CEO of BioWisdom.
"Feedback from long term customers, such as Boehringer Ingelheim, is essential for the SRS team to continue to provide software with a strong value proposition and we are pleased to be working with them for another year."
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE